← Back to all signals
RESEARCH PAPER ANALYSIS

Accelerated Aging in Survivors of Childhood Cancer-Early Onset and Excess Risk of Chronic Conditions.

AI interpretation is pending for this paper.

Open original publication →
PMID40111318
JournalJAMA oncology
Publication Date2025-05-01
Ingested2026-08-02 12:04 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

IMPORTANCE: The lifetime risk of aging-related diseases among survivors of childhood cancer, accelerated by cancer treatment exposures, is unknown. Understanding this risk can provide a more comprehensive assessment of long-term health across the lifespan of survivors and guide adult care. OBJECTIVE: To estimate the lifetime risks of 8 treatment-related cancers and cardiovascular conditions among childhood cancer survivors and compare them with the general population. DESIGN, SETTING, PARTICIPANTS: Using data from the Childhood Cancer Survivor Study and national databases, this simulation modeling study projected long-term outcomes for 5-year survivors diagnosed between 1970 and 1999 based on treatment exposures and age-related risks. The general population comparator was simulated using age-, sex-, and calendar year-matched individuals who faced only age-related risks. EXPOSURES: Treatment era (1970s, 1980s, 1990s), original cancer diagnosis, radiation treatment for primary diagnosis (any, none). MAIN OUTCOMES AND MEASURES: Estimated lifetime risks of 8 health conditions (breast cancer, colorectal cancer, glial tumors, sarcomas, heart failure, coronary heart disease/myocardial infarction, stroke, and valvular disease). Risks were projected and compared with the general population, stratified by radiation exposure. RESULTS: In the general population, 20% developed at least 1 health condition by age 65.0 years; in 5-year survivors this threshold was reached at age 47.3 years, representing a 17.7-year (95% uncertainty interval [UI], 14.0-21.0) acceleration in disease onset. By age 65 years, 55% of survivors were projected to develop at least 1 condition, indicating a 2.7-fold (95% UI, 2.2-3.5) higher relative risk and 34.2% (95% UI, 28.3-42.5) absolute excess risk compared with the general population. Risks were higher among those treated with radiation therapy for childhood cancer (22.0 years earlier onset [95% UI, 18.0-25.0]; 37.3% excess risk [95% UI, 31.6%-44.7%]) but still elevated for those without radiation exposure (13.5 years earlier onset [95% UI, 10.0-16.0]; 31.0% excess risk [95% UI, 23.9%-40.3%]). Reaching middle age was still associated with increased health risks. Compared with the general population, survivors who reached age 40 years had a 6.2-fold higher risk (95% UI, 4.8-9.4) of developing a new condition within 10 years. CONCLUSIONS AND RELEVANCE: This study found that survivors of childhood cancer experience accelerated onset of aging-related diseases, regardless of prior radiation exposure. These findings underscore the importance of prioritizing cancer and cardiovascular disease prevention among survivors decades earlier than for the general population.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Age- and Sex-Related Differences in Primary Cutaneous Lymphoma. Cutis 59.4 2 Evaluating the consequences of childhood adiposity on the human plasma proteome at four timepoints across the lifecourse. Nature communications 38.2 3 CReP-mediated control of eIF2α phosphorylation is a critical node in MYC-driven medulloblastoma. Nature communications 58.4 4 DICER1 genetics and their impact on the diagnosis and management of lung lesions: A scoping review. Paediatric respiratory reviews 63.4 5 Sex- and age-stratified pharmacovigilance of methotrexate-associated adverse events in pediatric leukemia: a FAERS-based study. Frontiers in medicine 66.72 6 Case Report: Dasatinib-associated chylothorax and occult Bartonella henselae infection in pediatric leukemia: a case report and systematic review. Frontiers in pharmacology 75.6 7 B7-H3-mediated immune regulation in cancer: biological functions and therapeutic opportunities. Frontiers in pharmacology 67.04 8 Machine learning prediction model for distant metastasis at diagnosis in pediatric neuroblastoma: development, interpretation, and temporal validation. Translational pediatrics 73.3 9 Lipid and immune profiles in children with systemic juvenile idiopathic arthritis: a case-control study with paired longitudinal comparison of disease activity. Translational pediatrics 71.0 10 Ethical dilemmas and intervention strategies in doctor-patient-family communication in end-of-life pediatric oncology: a narrative review. Translational pediatrics 63.6 11 Pediatric Large Cell/Anaplastic Medulloblastomas: Diagnostic Concordance and Multi-Classifier DNA Methylation Profiling, Including the In-House MAGIBU Framework. Neuropathology : official journal of the Japanese Society of Neuropathology 64.5 12 Under One Roof: Household Composition and Health-Related Quality of Life Among Cancer Survivors. Cancer medicine 65.5 13 The Role of Methylation Marker FAM19A4/mir124-2 and HPV Genotype in Active Surveillance of Women With Cervical Intraepithelial Neoplasia Grade 2 (CIN2). Journal of medical virology 71.9 14 Pediatric Liver Transplantation in the Treatment of Solid Liver Tumors: A Narrative Review. Pediatric transplantation 64.84 15 Medulloblastoma Spatial Transcriptomics Reveals Tumor Microenvironment Heterogeneity With High-Density Progenitor Cell Regions Correlating With High-Risk Disease. JCO precision oncology 65.6 16 From Cure to Quality of Life: The Shifting Frontier in Pediatric Acute Lymphoblastic Leukemia. Journal of the National Comprehensive Cancer Network : JNCCN 47.5 17 Adverse Family Outcomes in Children With B-Cell Acute Lymphoblastic Leukemia From the Multicenter Trial Children's Oncology Group AALL0932. Journal of the National Comprehensive Cancer Network : JNCCN 72.7 18 Pediatric conjunctival papilloma managed with staged multimodal therapy: a case report. BMC ophthalmology 50.74 19 Where Eastern Medicine Meets Western Medicine: A World Review of the Management of Chronic Cough. World journal of otorhinolaryngology - head and neck surgery 65.5 20 Nanoprobe-Enabled Precision Imaging and Panoramic Boundary Delineation in Retinoblastoma. Cancer innovation 63.5 21 Bridging therapy in pediatric and AYA patients under 25 years with relapsed/refractory B-ALL undergoing anti-CD19 CAR-T therapy: a multicenter retrospective study by the Spanish group GETH-TC. Bone marrow transplantation 82.98 22 Changes in pediatric oncology nurses' knowledge and observed mucormycosis-prevention practices following an educational programme: a one-group pretest-posttest study. BMC nursing 80.4 23 Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastoma. Cell reports 59.3 24 Atypical presacral masses in Currarino syndrome: a case series. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 54.5 25 First report of proven Fusarium brachygibbosum sinusitis in a paediatric patient with acute myeloblastic leukaemia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 55.2 26 Interpreting the Association Between Plasma Citrulline and Bloodstream Infection in Pediatric Acute Myeloid Leukemia. European journal of haematology 47.5 27 Trust in Retinoblastoma Care: Understanding Parent-Physician Relationships in Collectivist, Low-Resource Settings. Pediatric blood & cancer 60.9 28 Combined Bulk and Single-Cell RNA Sequencing Reveals Alterations in the Immune Microenvironment and Candidate Immune-Related Genes Associated With Diagnosis and Relapse in Childhood B-Cell Acute Lymphoblastic Leukemia. Pediatric blood & cancer 60.32 29 Phase II study of selpercatinib in children and young adults with RET-altered tumors: Arm N of the NCI-COG Pediatric MATCH trial (APEC1621). The oncologist 81.9 30 Genetic insights into pediatric congenital pulmonary airway malformations: a 13-year single-center experience. Pediatric surgery international 61.9 31 A case report of pediatric Gardner syndrome and literature review. Skeletal radiology 51.1 32 Changes In body composition and subsequent risk of relapse In childhood hodgkin lymphoma. Journal of the National Cancer Institute 73.92
PATIENT-FRIENDLY SUMMARY

Accelerated Aging in Survivors of Childhood Cancer-Early Onset and Excess Risk of Chronic Conditions.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic